And I take yours as well. The reason why there are not many technologies in anti-infection is multifold and include the economics of the market place. There is good work being done though - I remember AZ opening a new TB research centre in Bangalore a few years back which must have been quite an investment.
Distribution of medicines to the Developing World is a passion of mine, but people need to understand all the reasons for it not working as it should. In the area of infection I actually think that efficient distribution of currently available drugs is more important than developing new ones.
Your point about Universities is also interesting. They can innovate in a way that Pharma struggle to. In the UK at least, there is not strong enough partnering between Industry and Academia to develop innovation, hence the development of the AHSCs. Lots more to be done there.


LinkBack URL
About LinkBacks
. The reason why there are not many technologies in anti-infection is multifold and include the economics of the market place. There is good work being done though - I remember AZ opening a new TB research centre in Bangalore a few years back which must have been quite an investment.
Reply With Quote
wtf, that's not what a market imperfection is. If market imperfections could be solved by the markets then they wouldn't be market imperfections. A market imperfection would be a mutually beneficial trade between two parties causing severe negative consequences for a third party, or imperfect information rendering a crucial market non-existent. I don't know how to respond without feeling like I'm giving a lesson in economics for dummies.
